Joshua Whitehill is an associate in the firm’s Litigation Department and a member of its Intellectual Property Group. Mr. Whitehill focuses his practice on patent matters, with a concentration in the areas of biotechnology and pharmaceuticals. He joined Goodwin in 2010.

Experience

ERFAHRUNG

工作经历

Mr. Whitehill has participated in all phases of patent litigation, including pre-suit investigations, fact and expert discovery, trial and appeals to the Federal Circuit. Mr. Whitehill also has experience in preparing patent opinions (invalidity and clearance).

Representative matters include:

  • Pfizer Inc. et al. v. Teva Pharmaceuticals USA, Inc., No. 2:10-cv-00128-RBS-FBS (E.D. Va.). Representing Teva in patent infringement litigation filed by Pfizer under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of Pfizer’s VIAGRA® (sildenafil citrate) drug products.
  • Momenta Pharmaceuticals, Inc. et al. v. Teva Pharmaceuticals USA, Inc., No. 10-12079-NMG (D. Mass). Representing Teva in patent infringement litigation filed by Momenta and Sandoz concerning Teva’s generic version of Sanofi’s LOVENOX® (enoxaparin sodium) drug product.
  • ViiV Healthcare UK Ltd. et al. v. Teva Pharmaceuticals USA, Inc., No. 11-576-RGA (D. Del.). Representing Teva in patent infringement litigation filed by ViiV under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of ViiV’s EPZICOM® (abacavir sulfate and lamivudine) drug products.
  • Janssen Products, L.P. et al. v. Lupin Limited et al., No. 10-5954-WHW (D.N.J.). Representing Teva in patent infringement litigation filed by Janssen, the University of Illinois, and the United States Government under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of Janssen’s PREZISTA® (darunavir) drug products.
  • In re Bendamustine Consolidated Cases, No. 13-2046-GMS (D. Del.). Representing Cephalon in consolidated patent infringement litigations under the Hatch-Waxman Act against numerous generic pharmaceutical companies seeking approval to market generic versions of Cephalon’s TREANDA® (bendamustine hydrochloride) drug products.
  • Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc., No. 14-874-SLR-SRF (D. Del.). Representing Teva in patent infringement litigation filed by Merck under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of Merck’s NASONEX® (mometasone furoate monohydrate) drug products.
  • AstraZeneca Pharmaceuticals LP et al. v. Teva Pharmaceuticals USA, Inc., No. 14-1478-GMS (D. Del.). Representing Teva in patent infringement litigation filed by AstraZeneca under the Hatch-Waxman Act in response to Teva’s filing of an Abbreviated New Drug Application seeking approval to market a generic version of AstraZeneca’s BYETTA® (exenatide) drug products.
Professional Activities

Mr. Whitehill is a contributor to the firm’s Biosimilars Reference Guide and biosimilars blog, www.bigmoleculewatch.com.

Mr. Whitehill is a member of the New York Intellectual Property Law Association (NYIPLA), including its publications and patent litigation committees.

Mr. Whitehill’s pro bono work includes representing a U.S. Army veteran in pursuing appeals related to his claims for disability benefits.

Professional Experience

Prior to joining Goodwin, Mr. Whitehill worked as a paralegal and law clerk at Cooper & Dunham LLP, where he was involved in all aspects of U.S. patent prosecution and PCT international filings, particularly in the areas of pharmaceuticals, biologics and medical devices.

Recognition

While attending law school, Mr. Whitehill was a Notes and Comments Editor for the Brooklyn Journal of International Law.

In The News

MELDUNGEN

在新闻中

Credentials

WERDEGANG

专业资格

Education

J.D., 2009
Brooklyn Law School

(cum laude)

B.A., Chemistry, 2004
New York University

Admissions

Bar

New York

Courts

U.S. District Court for the Southern District of New York
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the Eastern District of New York
Get In Touch
KONTAKT
Get In Touch
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.
Unsere Kunden verlassen sich auf uns für erstklassige Beratungsdienste, beraten über komplexe Transaktionsarbeiten und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Industrie, verwenden wir eine kooperative, interdisziplinäre Ansatz zur Lösung unserer Kunden am schwierigsten Fragen. Um mehr zu erfahren, kontaktieren Sie uns bitte.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
搜寻其他律师